Document 0191 DOCN M95B0191 TI An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1. DT 9511 AU Hoover DR; Graham NM; Bacellar H; Murphy R; Visscher B; Anderson R; McArthur J; Johns Hopkins School of Hygiene and Public Health, Department of; Epidemiology, Baltimore, Maryland 21205, USA. SO Clin Infect Dis. 1995 May;20(5):1250-8. Unique Identifier : AIDSLINE MED/95345293 AB Cofactors associated with the Mycobacterium avium complex (MAC) disease and its prognosis in incident cases of AIDS in homosexuals were studied. We compared 51 men in whom MAC disease developed as the initial AIDS-defining illness (termed AIDS illness hereafter); 157 men who had MAC disease subsequent to another AIDS illness; and 884 men who had only non-MAC AIDS illnesses. MAC disease was the initially diagnosed AIDS illness more often in Baltimore (6.9%) and Los Angeles (5.6%) than in Chicago (2.6%) and Pittsburgh (0) (P < .01). MAC disease also was a more common subsequent AIDS illness in Baltimore (14.3%) and Los Angeles (22.4%) than in Chicago (8.5%) and Pittsburgh (6.5%) (P < .0001). Prophylaxis for Pneumocystis carinii infection increased the occurrence of MAC disease as the initial AIDS illness (from 2.3% to 12.5%; P < .0001). A low white blood cell (WBC) count was slightly more predictive of MAC disease than was a low CD4+ cell count. At 0-6, 7-12, and 13-18 months before diagnosis, the WBC cell counts of 75.0%, 61.1%, and 50.0%, respectively, of those with MAC disease as the initial AIDS illness were < or = 3,400/microL. Men in whom cytomegalovirus disease developed were at higher risk for subsequent MAC disease (relative hazard = 2.65; P < .0001). MAC disease also increased the risk for subsequent cytomegalovirus disease (relative hazard = 3.96; P < .0001). DE Adult Alcohol, Ethyl/ADVERSE EFFECTS AIDS-Related Opportunistic Infections/EPIDEMIOLOGY/*ETIOLOGY/ MORTALITY CD4 Lymphocyte Count *Homosexuality, Male Human Male Mycobacterium avium-intracellulare Infection/EPIDEMIOLOGY/ *ETIOLOGY/MORTALITY Risk Factors Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).